Ticagrelor (Tab 90 mg): Supply issue
Due to shipping delays, Sandoz has run out of ticagrelor tablets (Pharmacode: 2638770).
23 April 2026 | Update
Unfortunately, this page was updated in error to say that this product has been resupplied. Resupply of the registered Ticagrelor Sandoz is now expected in May 2026.
Stock of the alternative, Mylan, remains available.
Affected product
Unfortunately, because of a delayed shipment the supplier ran out of the following product.
- Chemical: Ticagrelor
- Presentation: Tab 90 mg
- Brand: Ticagrelor Sandoz
- Pharmacode: 2638770
- Subsidy: $20.35
- Measure / Qty: per 56
Alternative brand listed 1 March 2026
An alternative brand was listed from 1 March 2026. It is not registered with Medsafe and will have to be prescribed and dispensed in line with section 29A of the Medicines Act.
The alternative is from Italy. The box has an English label on it, but the blister packs will still be in Italian. The consumer information sheet will still be in Italian.
It contains the same active ingredient in the same amount, it is designed to work in the body the same way.
- Brand: Ticagrelor Mylan
- Pharmacode: 2724820
- Subsidy: $23.85
- Measure / Qty: per 56
Information for pharmacists
- RxOne users: The new listing will be automatically updated by RxOne on the effective date.
- TONIQ users: The new listing will automatically be updated in Toniq medicine databases from the effective date.
- ScriptSense users: The listing will be automatically updated by ScriptSense from the effective date.
Claiming
Please note Sector Operations Group will be unable to process claims for March 2026 dispensings of Ticagrelor Mylan.
Pharmacies can either:
- hold these claims until April 2026 OR
- re-claim them in April 2026 when they are rejected for payment in March 2026 claim.
Prescribing and supplying an unapproved medicine
Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people.
We know supplying an unapproved medicine. In this case, however, this will allow people to continue to access an appropriate treatment.
We apologise for any inconvenience this causes.
What patients need to know about unapproved medicines – Healthify website(external link)
- Ticagrelor supply issue flyer Feb 26 [PDF 420 KB]
Resupply expected May 2026
Sandoz, the supplier, expects stock of the product will be available again by early May 2026. It can take another 1 to 2 weeks to reach pharmacies around the country.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)